Results 191 to 200 of about 69,629 (300)

Enterococcus-driven metabolite-host gene networks in IBD-associated colorectal carcinogenesis: integrative multi-omics and experimental validation. [PDF]

Front Cell Dev Biol
Huang G, Liu J, Cheng Z, Chen Y, Chen K, Liu W, Liu H, Xia X, Lu M, Cui W, Zhang Q, Yuan Y, Zhong F, Liao Y.   +13 more
europepmc   +1 more source

Macroscale Gradient‐Informed Neural Oscillation Topography in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Parkinson's disease (PD) is characterized by large‐scale disruptions in beta and gamma oscillations. Although subcortical beta power is an established biomarker for current adaptive deep brain stimulation (aDBS), it may not fully capture the global pathophysiological burden and the macroscale hierarchical reorganization of the ...
Hao Ding, Ke Xie, Manuel Bange, Hannah Kühne, Jenny Blech, Bahman Nasseroleslami, Jens Volkmann, Sergiu Groppa, Muthuraman Muthuraman   +8 more
wiley   +1 more source

Exploring the Role of Food and Food-Related Compounds in Parkinson's Disease. [PDF]

Foods
Trezzi I, Rizzo G, Giampieri F, Battino M, Baroni L.   +4 more
europepmc   +1 more source

Levodopa [PDF]

, 2011
openaire   +1 more source

Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation

Movement Disorders, EarlyView.
Abstract Adaptive deep brain stimulation (aDBS) represents an important evolution in the treatment of Parkinson's disease (PD), building on conventional DBS (cDBS) by adjusting stimulation in response to real‐time physiological signals. By enabling dynamic targeting of disease‐related neural activity, aDBS offers the potential for more precise ...
Thomas Koeglsperger, Maximilian Scherer, Andrea A. Kühn, Alexandre Eusebio, Alfonso Fasano, Joachim K. Krauss   +5 more
wiley   +1 more source

Rare Abdominal Manifestations in a Patient with Parkinson's Disease after Deep Brain Stimulation of the Subthalamic Nucleus: A Case Report. [PDF]

Case Rep Neurol
Koyama H, Morigaki R, Miyake K, Matsuda T, Fujikawa J, Shinohara K, Nishida Y, Takagi Y.   +7 more
europepmc   +1 more source

Acute Inflammatory Demyelinating Polyradiculoneuropathy‐like Associated with Subcutaneous Foslevodopa–Foscarbidopa: First Report

Movement Disorders, EarlyView.
Heloise Cochez, Corentin Cazenave, Celestin Castagnet, Laure Balguerie, Blandine Acket, Margherita Fabbri, Fabienne Ory‐Magne   +6 more
wiley   +1 more source

Perspective: Depression in Persons with Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Depression is a prevalent and disabling syndrome characterized by sustained sadness and/or anhedonia, as well as cognitive and physical symptoms. In Parkinson's disease (PD), depression is both common and clinically challenging due to overlapping symptoms and complex etiologic interactions. Major depressive disorder occurs in approximately 17%
Albert F.G. Leentjens, Gregory M. Pontone   +1 more
wiley   +1 more source

Machine learning models for the prediction of levodopa response to tremor in Parkinson's disease. [PDF]

Front Aging Neurosci
Li F, Lin S, Yan R, Cui Y, Ren K, Chen Z, Ma L, Feng T.   +7 more
europepmc   +1 more source

At the extreme limits of L-DOPA therapy: probable dopamine dysregulation and psychiatric complications in Parkinson's disease. [PDF]

BMJ Neurol Open
Oikarinen N, Ottela E, Rönkä J, Haanpää M, Niemelä S, Lees AJ, Kaasinen V.   +6 more
europepmc   +1 more source